Results 261 to 270 of about 95,020 (310)
Some of the next articles are maybe not open access.
Intraperitoneal chemotherapy for ovarian cancer
Current Opinion in Oncology, 2006Intraperitoneal chemotherapy for ovarian cancer is based on sound pharmacological principles and is technically feasible. There is mounting evidence, bolstered by a recent randomized trial, that in certain patients, this route of delivery may be superior to traditional intravenous chemotherapy.
Chad A, Hamilton, Jonathan S, Berek
openaire +2 more sources
Intraperitoneal chemotherapy for colorectal cancer
Journal of Surgical Oncology, 2001AbstractThe peritoneal surface remains an important failure site for patients with colorectal cancer. Peritoneal metastases of colorectal cancer are at present considered equal to distant metastatic disease. Consequently, peritoneal carcinomatosis is treated with systemic chemotherapy and surgery only to palliate complications such as obstruction ...
Eelco, de Bree +2 more
openaire +2 more sources
Hyperthermic Intraperitoneal Chemotherapy
2017Peritoneal metastasis in abdominal malignancies is associated with a dismal prognosis. In the past, it was considered inoperable and the patient was considered a candidate for palliative chemotherapy alone. The outcome of systemic chemotherapy is poor with the average survival being 6–8 months.
Nikhil Gupta, Shivendra Singh
openaire +1 more source
Carrier solutions for intraperitoneal chemotherapy
Surgical Oncology Clinics of North America, 2003Two pharmacokinetic problems appear to limit the effectiveness of intraperitoneal therapy: poor tumor penetration and nonuniform intraperitoneal distribution by the drug-containing solution. A better understanding of the pharmacodynamics of carrier solutions for intraperitoneal chemotherapy may impact on both these problems.
Faheez, Mohamed, Paul H, Sugarbaker
openaire +2 more sources
Neutropenia following Perioperative Intraperitoneal Chemotherapy
Tumori Journal, 1999Introduction The purpose of this retrospective report was to evaluate clinical features associated with profound neutropenia in patients with peritoneal carcinomatosis who were treated with heated intraoperative intraperitoneal chemotherapy (HIIC) followed by early postoperative intraperitoneal chemotherapy (EPIC).
K J, Schnake, P H, Sugarbaker, D, Yoo
openaire +2 more sources
[Hyperthermic intraperitoneal chemotherapy].
Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen, 2019Cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) are recognized as the standard of care for selected patients with peritoneal malignancies. A complete macroscopic cytoreduction is the basis for a successful multimodal treatment. The significance of intraperitoneal chemotherapy is still under discussion.
H, Leebmann, P, Piso
openaire +1 more source
Nihon rinsho. Japanese journal of clinical medicine, 2013
Ying Xiao +56 more
openaire +3 more sources
Ying Xiao +56 more
openaire +3 more sources
[Intraperitoneal chemotherapy].
Gan to kagaku ryoho. Cancer & chemotherapy, 1989A fact that the Second International Conference of Intracavitary Chemotherapy was held at Sandiego in 1988 clearly suggests that the intraperitoneal chemotherapy attracts again the attention as a new administration route aimed at complete cure and useful modality against refractory intraabdominal cancer.
openaire +1 more source